INR Breakthrough Videos

The stunning clinical results seen with the patented INR anti-TNF treatment for Alzheimer’s disease, other forms of dementia, and to enhance neurological recovery following stroke are unprecedented[1-3]. Their scientific basis depends on the fact that the INR approach is the first to directly target TNF, an immune signaling molecule present in great excess in the AD brain and central to brain dysfunction following stroke. The following videos are included to help illustrate the range of clinical effects that may occur following initiation of anti-TNF treatment at the INR. All videos are of actual INR patients, depicting their actual results, with commentary by their family members.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment is necessary to maintain the clinical response in dementia. Anti-TNF treatment for the indications below is off-label. Please see the Terms of Use. Maintenance dosing, usually weekly, but sometimes as little as monthly, is necessary for optimal effect in dementia. The method of local anti-TNF treatment utilized for these patients is a patented invention of the INR.

1. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
   Edward Tobinick MD. CNS Drugs. 2011 Feb 1;25(2):145-55.
2. Perispinal etanercept: a new therapeutic paradigm in neurology. Edward Tobinick MD. Expert Review of Neurotherapeutics. 2010 Jun;10(6):985-1002.
3. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer’s disease.
   Tobinick EL, Gross H. BMC Neurology. 2008 Jul 21;8:27.